arbekacin and Sepsis

arbekacin has been researched along with Sepsis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda, Y; Hashiguchi, K; Imamura, Y; Inoue, Y; Izumikawa, K; Kakeya, H; Kobayashi, T; Kohno, S; Kondo, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Yamamoto, Y; Yanagihara, K1
Akiyama, N; Arai, T; Hanaki, H; Higashihara, M; Ichiwata, T; Ikegami, K; Kimura, T; Kobayashi, M; Matsumoto, T; Miyao, N; Nemoto, M; Oda, S; Ohyashiki, K; Otsuka, Y; Soma, K; Sunakawa, K; Suzuki, Y; Totsuka, K; Yokota, H; Yoshida, M; Yukioka, T1
Aikawa, N; Kaku, M; Morita, K; Sato, R; Shimizu, K; Tanigawara, Y1
Aihara, Y; Fukamachi, K; Hori, T; Imamura, T; Kasuya, H; Kawashima, A; Kikuchi, K; Ochiai, T; Shiseki, M; Tozuka, K; Yamaguchi, K1
Arakawa, M; kawashima, T; Tsukasa, H; Wada, K1
Bouanchaud, DH; Rolin, O1

Trials

1 trial(s) available for arbekacin and Sepsis

ArticleYear
The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Dibekacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Sepsis; Staphylococcal Infections; Treatment Outcome

2012

Other Studies

5 other study(ies) available for arbekacin and Sepsis

ArticleYear
Clinical efficacy and safety of arbekacin sulfate in patients with MRSA sepsis or pneumonia: a multi-institutional study.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Dibekacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Japan; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Sepsis

2013
Population pharmacokinetics of Arbekacin in patients infected with methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Aminoglycosides; Anti-Bacterial Agents; Child; Dibekacin; Dose-Response Relationship, Drug; Female; Humans; Male; Methicillin Resistance; Middle Aged; Models, Statistical; Population; Reproducibility of Results; Sepsis; Staphylococcal Infections

2006
[Two cases of methicillin-resistant Staphylococcus aureus (MRSA) sepsis following craniotomy].
    No shinkei geka. Neurological surgery, 2000, Volume: 28, Issue:5

    Topics: Adult; Aged; Alanine; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Craniotomy; Dibekacin; Drug Therapy, Combination; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Methicillin Resistance; Postoperative Complications; Sepsis; Staphylococcal Infections; Sulbactam; Thienamycins; Treatment Outcome; Vancomycin

2000
[Septicemia caused by MRSA].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1992, Oct-10, Volume: 81, Issue:10

    Topics: Aminoglycosides; Anti-Bacterial Agents; Catheterization; Dibekacin; Equipment Contamination; Humans; Methicillin Resistance; Prognosis; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1992
Protective activity of habekacin and four other aminoglycosides in mouse septicaemia caused by Enterobacteriaceae.
    Drugs under experimental and clinical research, 1986, Volume: 12, Issue:11

    Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Enterobacteriaceae Infections; Female; Gentamicins; Kanamycin; Male; Mice; Microbial Sensitivity Tests; Sepsis; Tobramycin

1986